NDAORALCAPSULE, DELAYED REL PELLETS, TABLET
Approved
Nov 2003
Lifecycle
LOE Approaching
Competitive Pressure
30/100
Data completeness
1/8 — Limited
Drug data last refreshed 2d ago · AI intelligence enriched 3w ago
AI summarySynthesized from FDA + DailyMed + ClinicalTrials.gov data
PREVACID NAPRAPAC 250 is a fixed-dose combination copackaging lansoprazole (a proton pump inhibitor) with naproxen (an NSAID) for oral administration. It is indicated for patients requiring NSAID therapy who are at risk for NSAID-induced gastric ulcers, with the lansoprazole component providing gastroprotection. The product combines two distinct mechanisms: PPI-mediated acid suppression and NSAID-mediated anti-inflammatory/analgesic activity.
LOE Approaching
Product approaching loss of exclusivity with competitive pressure at 30%, signaling potential team restructuring and shift toward generic support or product line consolidation.
Mechanism of Action
Mechanism of action data is being enriched from DailyMed and FDA sources. Check back soon for updated drug intelligence.
Indications
Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.
Career Relevance
Working on PREVACID NAPRAPAC offers limited career growth opportunities given its approaching loss of exclusivity and low linked job count. Professionals on this brand should expect team downsizing and should position themselves for transition to growth-stage products or defensive/managed care roles.
Brand ManagerSales Representative
Worked on PREVACID NAPRAPAC 250 (COPACKAGED) at Takeda? Share your interview experience or compensation data (+7 days Pro)
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.